These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7692470)

  • 1. [Substance P receptor antagonist].
    Kiyoto S
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1841-52. PubMed ID: 7692470
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a new dual neurokinin antagonist on airway smooth muscle in situ.
    Shioya T; Kagaya M; Sano M; Itaba M; Shindo T; Fujii T; Miura M
    Arzneimittelforschung; 1995 Nov; 45(11):1194-7. PubMed ID: 8929238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors and antagonists for substance P and related peptides.
    Regoli D; Boudon A; Fauchére JL
    Pharmacol Rev; 1994 Dec; 46(4):551-99. PubMed ID: 7534932
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
    Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.
    Porcelli M; Casu M; Lai A; Saba G; Pinori M; Cappelletti S; Mascagni P
    Biopolymers; 1999 Aug; 50(2):211-9. PubMed ID: 10380345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for tachykinins in female mouse and rat reproductive function.
    Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
    Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
    Lördal M; Bränström R; Hellström PM
    Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for NK(1) and NK(2) receptors in the motor activity in mouse colon.
    Mulè F; Amato A; Serio R
    Eur J Pharmacol; 2007 Sep; 570(1-3):196-202. PubMed ID: 17597603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.
    Kudlacz EM; Shatzer SA; Knippenberg RW; Logan DE; Poirot M; van Giersbergen PL; Burkholder TP
    J Pharmacol Exp Ther; 1996 May; 277(2):840-51. PubMed ID: 8627566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P equals pain substance?
    Iversen L
    Nature; 1998 Mar; 392(6674):334-5. PubMed ID: 9537317
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.
    Hirschmann R; Yao W; Cascieri MA; Strader CD; Maechler L; Cichy-Knight MA; Hynes J; van Rijn RD; Sprengeler PA; Smith AB
    J Med Chem; 1996 Jun; 39(13):2441-8. PubMed ID: 8691440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
    Abdel-Gawad M; Dion SB; Elhilali MM
    J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinins and tachykinin-receptors in the rat pineal gland.
    Mukda S; Chetsawang B; Govitrapong P; Schmidt PT; Hay-Schmidt A; Møller M
    Eur J Neurosci; 2005 May; 21(10):2743-51. PubMed ID: 15926922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Ca2+ signaling in tachykinin-mediated contractile responses in swine trachea.
    Lin YR; Kao PC; Chan MH
    J Biomed Sci; 2005; 12(3):547-58. PubMed ID: 15971006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
    Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP
    Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor.
    Gether U; Johansen TE; Snider RM; Lowe JA; Emonds-Alt X; Yokota Y; Nakanishi S; Schwartz TW
    Regul Pept; 1993 Jul; 46(1-2):49-58. PubMed ID: 7692567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.